Whereas, in another study in the same year which focused on hormone-dependent endometrial carcinoma had shown that HER2 positivity with negative hormone receptors status - oestrogen (ER) and progesterone (PR) were correlated with poorer outcome. The gene discussed is ERBB2; the disease is endometrial carcinoma.